PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wheaton Precious Metals Corp. (WPM)
96.701.20 (1.26%)
95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.03%
Negative revenue growth while FSM stands at 5.24%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
5.03%
Gross profit growth under 50% of FSM's 25.16%. Michael Burry would be concerned about a severe competitive disadvantage.
5.03%
EBIT growth below 50% of FSM's 117.93%. Michael Burry would suspect deeper competitive or cost structure issues.
5.03%
Operating income growth under 50% of FSM's 117.93%. Michael Burry would be concerned about deeper cost or sales issues.
-5.02%
Negative net income growth while FSM stands at 6661.40%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-7.14%
Negative EPS growth while FSM is at 7400.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-7.14%
Negative diluted EPS growth while FSM is at 7400.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-5.30%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-962.45%
Negative FCF growth while FSM is at 38.80%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
265.57%
10Y CAGR of 265.57% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
40.18%
5Y revenue/share CAGR at 50-75% of FSM's 75.90%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-37.68%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
679.42%
10Y OCF/share CAGR at 75-90% of FSM's 869.25%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
42.85%
5Y OCF/share CAGR at 50-75% of FSM's 71.74%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-48.13%
Negative 3Y OCF/share CAGR while FSM stands at 97.41%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
329.48%
Net income/share CAGR 1.25-1.5x FSM's 260.62%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
2.22%
Positive 5Y CAGR while FSM is negative. John Neff might view this as a strong mid-term relative advantage.
-67.99%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
1148.91%
Below 50% of FSM's 6459.67%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
129.90%
5Y equity/share CAGR above 1.5x FSM's 41.21%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
52.76%
3Y equity/share CAGR above 1.5x FSM's 9.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.08%
Firm’s AR is declining while FSM shows 0.66%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
13.35%
Asset growth above 1.5x FSM's 0.27%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
22.01%
BV/share growth above 1.5x FSM's 0.21%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-19.88%
We’re deleveraging while FSM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-3.79%
We cut SG&A while FSM invests at 3.69%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.